Leveraging the dual role of ROS in liver diseases with nanomaterials: clearing and amplifying for therapy

Abstract

The dual role of reactive oxygen species (ROS) in various liver diseases leads to the potential of nanomaterials in addressing challenges related to liver conditions. Considering the pivotal role of ROS in liver disease progression, the design and application of nanomaterials need to align with distinct disease characteristics and the unique liver microenvironment. By reviewing the interaction between nanomaterials and ROS in liver diseases and their potential applications in liver disease treatment, this work discusses the multifaceted properties of nanomaterials and their high specificity and prospects in liver disease treatments.

Graphical abstract: Leveraging the dual role of ROS in liver diseases with nanomaterials: clearing and amplifying for therapy

Article information

Article type
Minireview
Submitted
28 Oct 2024
Accepted
14 Dec 2024
First published
17 Dec 2024

Nanoscale, 2025, Advance Article

Leveraging the dual role of ROS in liver diseases with nanomaterials: clearing and amplifying for therapy

Z. Liu, Z. Yao, H. Yang, S. Wu and Z. Tang, Nanoscale, 2025, Advance Article , DOI: 10.1039/D4NR04469J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements